Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.49 USD | -0.11% |
|
+6.63% | +61.95% |
05-14 | Earnings Flash (BSEM) BIOSTEM TECHNOLOGIES Reports Q1 Revenue $41.9M | MT |
2023 | NovaBay to Commercialize BioStem's Amniotic Tissue Allograft | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
BIOSTEM TECHN. | Bio Therapeutic Drugs | -0.11% | +6.63% | - | - | - | 0 | - | - | - |
Technical Rankings Surperformance
- Stock Market
- Equities
- Stock
- BSEM Stock
- Charts BioStem Techn.
- Comparison Chart